http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110257521-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2019-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110257521-B |
| titleOfInvention | Application of miRNA-30a and its target genes in the detection of lung cancer |
| abstract | The invention relates to the application of miRNA-30a and its target gene in detecting lung cancer. Lung cancer is currently the most common malignant tumor in the world. Although some tumor markers are clinically used to diagnose lung cancer, the sensitivity and specificity of detection are limited. Looking for new tumor markers or new marker combinations related to the diagnosis of lung cancer Drugs are very important for the early diagnosis of lung cancer. The inventors used high-throughput sequencing and data analysis to screen out good lung cancer markers, providing a new target for clinical diagnosis of lung cancer genes. |
| priorityDate | 2019-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 130.